Selective vulnerability in neurodegenerative diseases

WGCNA: an R package for weighted correlation network analysis

Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases

Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · see citing works

A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268 · see citing works

Cryo-EM structures of tau filaments from Alzheimer’s disease

Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061 · see citing works

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854 · see citing works

A gene-based association method for mapping traits using reference transcriptome data

Gamazon, E. R., Wheeler, H. E., Shah, K. P., Mozaffari, S. V., Aquino-Michaels, K., Carroll, R. J., Eyler, A. E., Denny, J. C., Nicolae, D. L., Cox, N. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3367 · Cited by 1,762 · see citing works

Normal oxidative damage to mitochondrial and nuclear DNA is extensive.

Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,730 · see citing works

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · see citing works

Rapid single-step induction of functional neurons from human pluripotent stem cells

Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · see citing works

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · see citing works

The Biology of Proteostasis in Aging and Disease

Labbadia, J., & Morimoto, R. I. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033955 · Cited by 1,472 · see citing works

ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,426 · see citing works

APRIORITY

Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290 · see citing works

An environment-dependent transcriptional network specifies human microglia identity

Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,252 · see citing works

Ageing and neuronal vulnerability

Mattson, M. P., & Magnus, T. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1886 · Cited by 1,075 · see citing works

Massively parallel single-nucleus RNA-seq with DroNc-seq

Habib, N., Avraham-Davidi, I., Basu, A., Burks, T., Shekhar, K., Hofree, M., Choudhury, S. R., Aguet, F., Gelfand, E., Ardlie, K., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4407 · Cited by 1,069 · see citing works

Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., Suh, E., Van Deerlin, V. M., Wood, E. M., Baek, Y., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23937 · Cited by 1,065 · see citing works

Ambra1 regulates autophagy and development of the nervous system

Fimia, G. M., Stoykova, A., Romagnoli, A., Giunta, L., Bartolomeo, S. D., Nardacci, R., Corazzari, M., Fuoco, C., Uçar, A., Schwartz, P. J., et al. (2007) · Nature · doi:10.1038/nature05925 · Cited by 1,048 · see citing works

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

Gremer, L., Schölzel, D., Schenk, C., Reinartz, E., Labahn, J., Ravelli, R. B. G., Tusche, M., López‐Iglesias, C., Hoyer, W., Heise, H., et al. (2017) · Science · doi:10.1126/science.aao2825 · Cited by 1,031 · see citing works

Differential loss of striatal projection neurons in Huntington disease.

Reiner, A. J., Albin, R. L., Anderson, K. D., D’Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 999 · see citing works

Highly Multiplexed Subcellular RNA Sequencing in Situ

Lee, J. H., Daugharthy, E. R., Scheiman, J., Kalhor, R., Yang, J. L., Ferrante, T. C., Terry, R., Jeanty, S. S. F., Li, C., Amamoto, R., et al. (2014) · Science · doi:10.1126/science.1250212 · Cited by 973 · see citing works

Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain

Lake, B. B., Ai, R., Kaeser, G. E., Salathia, N. S., Yung, Y. C., Liu, R., Wildberg, A., Gao, D., Fung, H.-L., Chen, S., et al. (2016) · Science · doi:10.1126/science.aaf1204 · Cited by 957 · see citing works

Proteostasis and aging

Kaushik, S., & Cuervo, A. M. (2015) · Nature Medicine · doi:10.1038/nm.4001 · Cited by 899 · see citing works

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 884 · see citing works

Spreading of pathology in neurodegenerative diseases: a focus on human studies

Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790 · see citing works

Human iPSC-based modeling of late-onset disease via progerin-induced aging

Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777 · see citing works

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

Bondareff, W., Mountjoy, C. Q., & Roth, M. (1982) · Neurology · doi:10.1212/wnl.32.2.164 · Cited by 693 · see citing works

Propagation of Tau aggregates and neurodegeneration

Goedert, M., Eisenberg, D. S., & Crowther, R. A. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031153 · Cited by 632 · see citing works

Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease

Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 600 · see citing works

Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 583 · see citing works

Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration

Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 561 · see citing works

Aging as an event of proteostasis collapse

Taylor, R. C., & Dillin, A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004440 · Cited by 538 · see citing works

Amyotrophic lateral sclerosis—a model of corticofugal axonal spread

Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., & Tredici, K. D. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.221 · Cited by 524 · see citing works

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease

Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524 · see citing works

Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice

Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 516 · see citing works

Oxidative stress and protein aggregation during biological aging

Squier, T. C. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00139-5 · Cited by 511 · see citing works

Excitatory amino acids and Alzheimer's disease

Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 482 · see citing works

Motor Neuron Diversity in Development and Disease

Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135722 · Cited by 472 · see citing works

Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease

Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 445 · see citing works

Invited review: Frontotemporal dementia caused by microtubule‐associated protein tau gene ( MAPT ) mutations: a chameleon for neuropathology and neuroimaging

Ghetti, B. F., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 440 · see citing works

Living on the edge with too many mouths to feed: Why dopamine neurons die

Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 439 · see citing works

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

Okamoto, S., Pouladi, M. A., Talantova, M. V., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 439 · see citing works

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease

Mendez, I. M., Sánchez‐Pernaute, R., Cooper, O., Viñuela, Á., Ferrari, D., Björklund, L., Dagher, A., & Ole Isacson, A. (2005) · Brain · doi:10.1093/brain/awh510 · Cited by 438 · see citing works

Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging

Soreq, L., Rose, J., Soreq, E., Hardy, J., Trabzuni, D., Cookson, M. R., Smith, C., Ryten, M., Patani, R., & Ule, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.011 · Cited by 419 · see citing works

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

Halliday, G. M., Li, Y. W., Blumbergs, P. C., JOH, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 409 · see citing works

Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis

Braak, H., & Braak, E. (1996) · Acta Neuropathologica · doi:10.1007/s004010050508 · Cited by 406 · see citing works

Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening

Wang, C., Ward, M. E., Chen, R., Liu, K., Tracy, T. E., Chen, X., Xie, M., Sohn, P. D., Ludwig, C., Meyer-Franke, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.019 · Cited by 400 · see citing works

What is the evidence that tau pathology spreads through prion-like propagation?

Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384 · see citing works

Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)

Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380 · see citing works

The role of calcium‐binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis

Alexianu, M. E., Ho, B., Mohamed, A. H., Bella, V. L., Smith, R. G., & Appel, S. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360608 · Cited by 374 · see citing works

Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff

Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372 · see citing works

Staging TDP-43 pathology in Alzheimer’s disease

Josephs, K. A., Murray, M. E., Whitwell, J. L., Parisi, J. E., Petrucelli, L., Jack, C. R., Petersen, R. C., & Dickson, D. W. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1211-9 · Cited by 366 · see citing works

Early frontotemporal dementia targets neurons unique to apes and humans

Seeley, W. W., Carlin, D. A., Allman, J. M., Macedo, M. N., Bush, C., Miller, B. L., & DeArmond, S. J. (2006) · Annals of Neurology · doi:10.1002/ana.21055 · Cited by 364 · see citing works

Neurodegenerative Diseases: Expanding the Prion Concept

Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361 · see citing works

Platelet mitochondria function in Parkinson's disease

Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358 · see citing works

Post mortem studies in Parkinson’s disease — is it possible to detect brain areas for specific symptoms?

Jellinger, K. A. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_1 · Cited by 349 · see citing works

Generation of pure GABAergic neurons by transcription factor programming

Yang, N., Chanda, S., Marro, S., Ng, Y.-H., Janas, J. A., Haag, D., Ang, C. E., Tang, Y., Flores, Q., Mall, M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4291 · Cited by 341 · see citing works

Pathogenesis of Parkinson's disease

Hirsch, E. C., Jenner, P., & Przedborski, S. (2013) · Movement Disorders · doi:10.1002/mds.25032 · Cited by 336 · see citing works

SELECTIVE LOSS OF NEURONES OF ORIGIN OF ADRENERGIC PROJECTION TO CEREBRAL CORTEX (NUCLEUS LOCUS COERULEUS) IN SENILE DEMENTIA

Bondareff, W. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92657-x · Cited by 332 · see citing works

Laser capture microscopy coupled with Smart-seq2 for precise spatial transcriptomic profiling

Nichterwitz, S., Chen, G., Benitez, J. A., Yilmaz, M., Storvall, H., Cao, M., Sandberg, R., Deng, Q., & Hedlund, E. (2016) · Nature Communications · doi:10.1038/ncomms12139 · Cited by 331 · see citing works

Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions

Swistowski, A., Peng, J., Liu, Q., Mali, P., Rao, M. S., Cheng, L., & Zeng, X. (2010) · Stem Cells · doi:10.1002/stem.499 · Cited by 317 · see citing works

NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum

Landwehrmeyer, G. B., Standaert, D. G., Testa, C. M., Penney, J., & Young, A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317 · see citing works

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · see citing works

Calcium ions in neuronal degeneration

Wojda, U., Salińska, E., & Kuźnicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 298 · see citing works

A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology

Matarin, M., Salih, D. A., Yasvoina, M., Cummings, D. M., Guelfi, S., Liu, W., Nahaboo Solim, M. A., Moens, T. G., Paublete, R. M., Ali, S. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.041 · Cited by 290 · see citing works

Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins

Ciryam, P., Tartaglia, G. G., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.043 · Cited by 270 · see citing works

Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer’s Disease

Fu, H., Rodriguez, G. A., Herman, M., Emrani, S., Nahmani, E., Barrett, G., Figueroa, H. Y., Goldberg, E., Hussaini, S. A., & Duff, K. E. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.023 · Cited by 264 · see citing works

Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis

Shaw, P. J., & Eggett, C. J. (2000) · Journal of Neurology · doi:10.1007/bf03161151 · Cited by 262 · see citing works

Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration

Rabinovici, G. D., Seeley, W. W., Kim, E. J., Gorno‐Tempini, M. L., Rascovsky, K., Pagliaro, T. A., Allison, S. C., Halabi, C., Kramer, J. H., Johnson, J. K., et al. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507308779 · Cited by 261 · see citing works

Striatal neurons directly converted from Huntington’s disease patient fibroblasts recapitulate age-associated disease phenotypes

Victor, M. B., Richner, M., Olsen, H. E., Lee, S. W., Monteys, A. M., Ma, C., Huh, C. J., Zhang, B., Davidson, B. L., Yang, X. W., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0075-7 · Cited by 246 · see citing works

Chapter 37 Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease

Morrison, J. H., & Hof, P. R. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)36039-4 · Cited by 241 · see citing works

Calcium homeostasis, selective vulnerability and Parkinson's disease

Chan, C. S., Gertler, T. S., & Surmeier, D. J. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.01.006 · Cited by 239 · see citing works

Selective functional, regional, and neuronal vulnerability in frontotemporal dementia

Seeley, W. W. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168e2d · Cited by 235 · see citing works

Improved Cell Therapy Protocols for Parkinson's Disease Based on Differentiation Efficiency and Safety of hESC-, hiPSC-, and Non-Human Primate iPSC-Derived Dopaminergic Neurons

Sundberg, M., Bogetofte, H., Lawson, T., Jansson, J. P., Smith, G. A., Astradsson, A., Moore, M. A., Osborn, T. M., Cooper, O., Spealman, R. D., et al. (2013) · Stem Cells · doi:10.1002/stem.1415 · Cited by 223 · see citing works

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease

Surmeier, D. J., Guzmán, J. N., & Sánchez-Padilla, J. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.003 · Cited by 221 · see citing works

Peptide dimer structure in an Aβ(1–42) fibril visualized with cryo-EM

Schmidt, M., Rohou, A. L., Lasker, K., Yadav, J. K., Schiene‐Fischer, C., Fändrich, M., & Grigorieff, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503455112 · Cited by 219 · see citing works

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update

Brichta, L., & Greengard, P. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00152 · Cited by 214 · see citing works

Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease

Stranahan, A. M., & Mattson, M. P. (2010) · Neural Plasticity · doi:10.1155/2010/108190 · Cited by 198 · see citing works

Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS

Sun, S., Sun, Y., Ling, S., Ferraiuolo, L., McAlonis‐Downes, M., Zou, Y., Drenner, K., Wang, Y., Ditsworth, D., Tokunaga, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520639112 · Cited by 194 · see citing works

Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease

Chin, J., Massaro, C. M., Palop, J. J., Thwin, M. T., Yu, G.-Q., Bien-Ly, N., Bender, A., & Mucke, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3758-06.2007 · Cited by 188 · see citing works

Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS

von Lewinski, F., & Keller, B. U. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.07.001 · Cited by 186 · see citing works

Parkinson's Disease Is Not Simply a Prion Disorder

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 186 · see citing works

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9

Bussière, T., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10760 · Cited by 185 · see citing works

Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration

Tsvetkov, A. S., Arrasate, M., Barmada, S., Ando, D. M., Sharma, P., Shaby, B. A., & Finkbeiner, S. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1308 · Cited by 178 · see citing works

Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism

Greene, J. G., Dingledine, R. J., & Greenamyre, J. T. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.003 · Cited by 174 · see citing works

Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases

Ciryam, P., Kundra, R., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.004 · Cited by 173 · see citing works

Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease

Hof, P. R., Nimchinsky, E. A., Celio, M. R., Bouras, C., & Morrison, J. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90504-e · Cited by 172 · see citing works

Differential vulnerability of neurons in Huntington’s disease: the role of cell type‐specific features

Han, I., You, Y., Kordower, J. H., Brady, S. T., & Morfini, G. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06672.x · Cited by 171 · see citing works

Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: Reciprocal networks and neuronal evolution

Seeley, W. W., Allman, J. M., Carlin, D. A., Crawford, R. K., Macedo, M. N., Greicius, M. D., DeArmond, S. J., & Miller, B. L. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c0f14 · Cited by 165 · see citing works

A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease

Morrison, J. H., Lewis, D. A., Campbell, M. J., Huntley, G. W., Benson, D. L., & Bouras, C. (1987) · Brain Research · doi:10.1016/0006-8993(87)90914-0 · Cited by 164 · see citing works

Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology

Mishizen-Eberz, A. J., Rissman, R. A., Carter, T. L., Ikonomovic, M. D., Wolfe, B. B., & Armstrong, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.016 · Cited by 156 · see citing works

Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients

Richfield, E. K., Maguire‐Zeiss, K. A., Vonkeman, H. E., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410380605 · Cited by 153 · see citing works

Changes in Properties of Serine 129 Phosphorylated α-Synuclein with Progression of Lewy Type Histopathology in Human Brains

Walker, D., Lue, L., Adler, C., Shill, H. A., Caviness, J., Sabbagh, M., Akiyama, H., Serrano, G., Sue, L., & Beach, T. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.020 · Cited by 150 · see citing works

Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model

Kingsbury, A. E., Bandopadhyay, R., Silveira‐Moriyama, L., Ayling, H., Kallis, C., Sterlacci, W., Maeir, H., Poewe, W. H., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.23305 · Cited by 142 · see citing works

Selective vulnerabilities of N-methyl-D-aspartate (NMDA) receptors during brain aging

Magnusson (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00011 · Cited by 124 · see citing works

The natural history of central motor abnormalities in amyotrophic lateral sclerosis

Mills, K. R. (2003) · Brain · doi:10.1093/brain/awg260 · Cited by 124 · see citing works

Determinants of neuronal vulnerability in neurodegenerative diseases

Morrison, B. M., Hof, P. R., & Morrison, J. H. (1998) · Annals of Neurology · doi:10.1002/ana.410440706 · Cited by 120 · see citing works

Mitochondrial dynamics and quality control in Huntington's disease

Guedes-Dias, P., Pinho, B. R., Soares, T. R., de Proença, J., Duchen, M. R., & Oliveira, J. M. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.008 · Cited by 119 · see citing works

From Intrinsic Firing Properties to Selective Neuronal Vulnerability in Neurodegenerative Diseases

Roselli, F., & Caroni, P. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.063 · Cited by 117 · see citing works

The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections

Sarter, M. F., & Bruno, J. P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02004.x · Cited by 113 · see citing works

Direct Induction and Functional Maturation of Forebrain GABAergic Neurons from Human Pluripotent Stem Cells

Sun, A. X., Yuan, Q., Tan, S., Xiao, Y., Wang, D., Khoo, A., Sani, L., Tran, H.-D., Kim, P., Chiew, Y. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.035 · Cited by 111 · see citing works

Mitochondrial function in Parkinson's disease

Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Krige, D., Jenner, P. G., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320720 · Cited by 106 · see citing works

Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: ‘permissive templating’ as a general mechanism underlying neurodegeneration

Hardy, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330578 · Cited by 105 · see citing works

Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum

K�ppenbender, K. D., Standaert, D. G., Feuerstein, T. J., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000417)419:4 · Cited by 104 · see citing works

Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability

Silva, M. C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M. H. U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.001 · Cited by 103 · see citing works

The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family

Spina, S., Farlow, M. R., Unverzagt, F. W., Kareken, D. A., Murrell, J. R., Fraser, G. M., Epperson, F., Crowther, R. A., Spillantini, M. G., Goedert, M., et al. (2007) · Brain · doi:10.1093/brain/awm280 · Cited by 102 · see citing works

Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS

Ciryam, P., Lambert-Smith, I. A., Bean, D. M., Freer, R., Cid, F., Tartaglia, G. G., Saunders, D. N., Wilson, M. R., Oliver, S. G., Morimoto, R. I., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613854114 · Cited by 100 · see citing works

A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease

Freer, R., Sormanni, P., Vecchi, G., Ciryam, P., Dobson, C. M., & Vendruscolo, M. (2016) · Science Advances · doi:10.1126/sciadv.1600947 · Cited by 97 · see citing works

Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease

Kundra, R., Ciryam, P., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618417114 · Cited by 90 · see citing works

Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions

Bender, A., Schwarzkopf, R.-M., McMillan, A., Krishnan, K. J., Rieder, G., Neumann, M., Elstner, M., Turnbull, D. M., & Klopstock, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0892-9 · Cited by 88 · see citing works

A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation

Ciryam, P., Kundra, R., Freer, R., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516604113 · Cited by 84 · see citing works

Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons

Imamura, K., Sahara, N., Kanaan, N. M., Tsukita, K., Kondo, T., Kutoku, Y., Ohsawa, Y., Sunada, Y., Kawakami, K., Hotta, A., et al. (2016) · Scientific Reports · doi:10.1038/srep34904 · Cited by 84 · see citing works

Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability

Muratore, C., Zhou, C. Q., Liao, M., Fernandez, M. A., Taylor, W. M., Lagomarsino, V. N., Pearse, R. V., Rice, H. C., Negri, J. M., He, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.015 · Cited by 82 · see citing works

Localization of immunoreactivity for Deleted in Colorectal Cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents

Osborne, P. B., Halliday, G. M., Cooper, H. M., & Keast, J. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.043 · Cited by 77 · see citing works

Single cell gene expression profiling in Alzheimer’s disease

Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76 · see citing works

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity

Morigaki, R., & Goto, S. (2017) · Brain Sciences · doi:10.3390/brainsci7060063 · Cited by 76 · see citing works

L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner

Wang, Y., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.007 · Cited by 72 · see citing works

Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

Mattsson, N., Schott, J. M., Hardy, J., Turner, M. R., & Zetterberg, H. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311321 · Cited by 71 · see citing works

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease

Galvan, L., André, V. M., Wang, E. A., Cepeda, C., & Levine, M. S. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-2012-120009 · Cited by 69 · see citing works

Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease

Ginsberg, S. D., Malek‐Ahmadi, M. H., Alldred, M. J., Che, S., Elarova, I., Chen, Y., Jeanneteau, F. D., Kranz, T. M., Chao, M. V., Counts, S., et al. (2017) · Hippocampus · doi:10.1002/hipo.22802 · Cited by 69 · see citing works

Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease

Lee, H., Ogawa, O., Zhu, X., O’Neill, M. J., Petersen, R. B., Castellani, R. J., Ghanbari, H., Perry, G. L., & Smith, M. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0820-8 · Cited by 68 · see citing works

Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction

Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E. (2009) · Annals of Neurology · doi:10.1002/ana.21578 · Cited by 68 · see citing works

Differential expression of GABAA and glycine receptors in ALS‐resistant vs. ALS‐vulnerable motoneurons: possible implications for selective vulnerability of motoneurons

Lorenzo, L.-É., Barbe, A., Portalier, P., Fritschy, J., & Bras, H. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04863.x · Cited by 60 · see citing works

Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks

Varrone, A., Pappatà, S., Caracò, C., Soricelli, A., Milan, G., Quarantelli, M., Alfano, B., Postiglione, A., & Salvatore, M. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0883-5 · Cited by 59 · see citing works

Neuronal vulnerability in Parkinson's disease

Double, K. L. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70018-9 · Cited by 59 · see citing works

Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases

Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 59 · see citing works

On the origin of Alzheimerʼs disease

Roberts, G. W., Nash, M., Ince, P. G., Royston, M. C., & Gentleman, S. M. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00001 · Cited by 58 · see citing works

Involvement of Onuf's nucleus in amyotrophic lateral sclerosis

Kihira, T., Yoshida, S., YOSHIMASU, F., WAKAYAMA, I., & YASE, Y. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05313-0 · Cited by 55 · see citing works

Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1

Shu, S., Zhu, H., Tang, N., Chen, W., Li, X., Li, H., Pei, L., Liu, D., Mu, Y., Tian, Q., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-16.2016 · Cited by 51 · see citing works

Rac1b Increases with Progressive Tau Pathology within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease

Perez, S. E., Getova, D. P., He, B., Counts, S., Geula, C., Désiré, L., Coutadeur, S., Peillon, H., Ginsberg, S. D., & Mufson, E. J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.027 · Cited by 43 · see citing works

Otx2 selectively controls the neurogenesis of specific neuronal subtypes of the ventral tegmental area and compensates En1-dependent neuronal loss and MPTP vulnerability

Giovannantonio, L. G. D., Salvio, M. D., Acampora, D., Prakash, N., Wurst, W., & Simeone, A. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.10.022 · Cited by 42 · see citing works

Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: implications for selective vulnerability of spinal motor neurons in amyotrophic lateral sclerosis

Tomiyama, M., Kimura, T., Maeda, T., Tanaka, H., Furusawa, K., Kurahashi, K., & Matsunaga, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00561-5 · Cited by 38 · see citing works

Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease

Tiernan, C. T., Ginsberg, S. D., Guillozet-Bongaarts, A. L., Ward, S., He, B., Kanaan, N. M., Mufson, E. J., Binder, L. I., & Counts, S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.031 · Cited by 37 · see citing works

Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease

Gerschütz, A., Heinsen, H., Grünblatt, E., Wagner, A. K., Bartl, J., Meißner, C., Fallgatter, A. J., Al‐Sarraj, S., Troakes, C., Ferrer, I., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131280 · Cited by 37 · see citing works

Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice

Götz, J., Schönrock, N., Vissel, B., & Ittner, L. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1143 · Cited by 36 · see citing works

Differential vulnerability, connectivity, and cell typology

Morrison, J. H. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90021-3 · Cited by 36 · see citing works

Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brain

Iwamoto, N., & Emson, P. C. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90764-k · Cited by 32 · see citing works

Differential expression of Group I metabotropic glutamate receptors in motoneurons at low and high risk for degeneration in ALS

Laslo, P., Lipski, J., & Funk, G. D. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00027 · Cited by 32 · see citing works

Specific Distribution of the Autophagic Protein GABARAPL1/GEC1 in the Developing and Adult Mouse Brain and Identification of Neuronal Populations Expressing GABARAPL1/GEC1

Grand, J. N. L., Bon, K., Fraîchard, A., Zhang, J., Jouvenot, M., Risold, P., Boyer‐Guittaut, M., & Delage-Mourroux, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063133 · Cited by 29 · see citing works

Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice

Johnson, N. R., Condello, C., Guan, S., Oehler, A., Becker, J., Gavidia, M., Carlson, G. A., Giles, K., & Prusiner, S. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717193114 · Cited by 26 · see citing works

Cholinergic neuron gene expression differences captured by translational profiling in a mouse model of Alzheimer's disease

McKeever, P. M., Kim, T. P., Hesketh, A. R., MacNair, L., Miletic, D., Favrin, G., Oliver, S. G., Zhang, Z., George‐Hyslop, P. S., & Robertson, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.014 · Cited by 24 · see citing works

Functional alterations in neural circuits in Alzheimer's disease

Simonian, N. A., & Hyman, B. T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00034-c · Cited by 23 · see citing works

Embryonic development of selectively vulnerable neurons in Parkinson’s disease

Oliveira, M. A. P., Balling, R., Smidt, M. P., & Fleming, R. M. T. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0022-4 · Cited by 23 · see citing works

Literacy as a determining factor for brain organization: from Lecours' contribution to the present day

Parente, M. A. D. M. P., Fonseca, R. P., & Scherer, L. C. (2008) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn20300002 · Cited by 19 · see citing works

Decreased expression of calretinin in the cerebral cortex and hippocampus of SOD1G93A transgenic mice

Chung, Y. H., Joo, K. M., Nam, R. H., Cho, M. H., Kim, D. J., Lee, W. B., & Ik, C. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.022 · Cited by 16 · see citing works

Catastrophic cliffs: a partial suggestion for selective vulnerability in neurodegenerative diseases

Hardy, J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150287 · Cited by 15 · see citing works

Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson’s Disease

Roessler, R., Boddeke, E., & Copray, S. C. V. M. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9369-4 · Cited by 12 · see citing works

Untitled work

Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3

Single-Cell Profiles of Retinal Ganglion Cells Differing in Resilience to Injury Reveal Neuroprotective Genes

Tran, N. M., Shekhar, K., Whitney, I. E., Jacobi, A., Benhar, I., Hong, G., Yan, W., Adiconis, X., Arnold, M. E., Lee, J. M., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.006 · Cited by 627 · see citing works

Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease

Kamath, T., Abdulraouf, A., Burris, S. J., Langlieb, J., Gazestani, V., Nadaf, N. M., Balderrama, K., Vanderburg, C., & Macosko, E. Z. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01061-1 · Cited by 552 · see citing works

Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease

Leng, K., Li, E., Eser, R., Piergies, A., Sit, R., Tan, M., Neff, N., Li, S. H., Rodriguez, R. D., Suemoto, C. K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00764-7 · Cited by 485 · see citing works

Astrocyte Heterogeneity: Impact to Brain Aging and Disease

Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387 · see citing works

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

Arnsten, A. F. T., Datta, D., Del Tredici, K., & Braak, H. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12192 · Cited by 361 · see citing works

A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders

Agarwal, D., Sandor, C., Volpato, V., Caffrey, T. M., Monzón‐Sandoval, J., Bowden, R. J., Alegre‐Abarrategui, J., Wade‐Martins, R., & Webber, C. (2020) · Nature Communications · doi:10.1038/s41467-020-17876-0 · Cited by 324 · see citing works

Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease

Piwecka, M., Rajewsky, N., & Rybak-Wolf, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00809-y · Cited by 320 · see citing works

Iron in Neurodegeneration – Cause or Consequence?

Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298 · see citing works

Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease

Otero-Garcia, M., Mahajani, S. U., Wakhloo, D., Tang, W., Xue, Y.-Q., Morabito, S., Pan, J., Oberhauser, J., Madira, A. E., Shakouri, T., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.021 · Cited by 262 · see citing works

A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology

Fu, H., Possenti, A., Freer, R., Nakano, Y., Villegas, N. C. H., Tang, M., Cauhy, P. M., Lassus, B., Chen, S., Fowler, S. L., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0298-7 · Cited by 252 · see citing works

Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?

Muddapu, V. R., Dharshini, S. P., Chakravarthy, V., & Gromiha, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00213 · Cited by 218 · see citing works

Functional Modules of the Proteostasis NetworkPreprint

Jayaraj, G. G., Hipp, M. S., & Hartl, F. U. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033951 · Cited by 249 · see citing works

Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell

Cong, Y., Motamedchaboki, K., Misal, S. A., Liang, Y., Guise, A. J., Truong, T., Huguet, R., Plowey, E. D., Zhu, Y., López‐Ferrer, D., et al. (2020) · Chemical Science · doi:10.1039/d0sc03636f · Cited by 229 · see citing works

Cellular and pathological heterogeneity of primary tauopathies

Chung, D. C., Roemer, S. F., Petrucelli, L., & Dickson, D. W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00476-x · Cited by 218 · see citing works

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

den Haan, J., Morrema, T. H. J., Verbraak, F. D., de Boer, J. F., Scheltens, P., Rozemüller, A. J. M., Bergen, A. A. B., Bouwman, F. H., & Hoozemans, J. J. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0650-x · Cited by 220 · see citing works

Motor Neuron Susceptibility in ALS/FTD

Ragagnin, A., Shadfar, S., Vidal, M., Jamali, M. S., & Atkin, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00532 · Cited by 216 · see citing works

Effects of curcumin on mitochondria in neurodegenerative diseases

Bagheri, H., Ghasemi, F., Barreto, G. E., Rafiee, R., Sathyapalan, T., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1566 · Cited by 211 · see citing works

Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways

Zhao, N., Ren, Y., Yamazaki, Y., Qiao, W., Li, F., Felton, L. M., Mahmoudiandehkordi, S., Kueider-Paisley, A., Sonoustoun, B., Arnold, M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.034 · Cited by 225 · see citing works

Autophagy in aging and longevity

Wong, S. Q., Kumar, A. V., Mills, J., & Lapierre, L. R. (2019) · Human Genetics · doi:10.1007/s00439-019-02031-7 · Cited by 204 · see citing works

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Najm, R., Jones, E. A., & Huang, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0324-6 · Cited by 183 · see citing works

Compilation of reported protein changes in the brain in Alzheimer's disease

Askenazi, M., Kavanagh, T., Pires, G., Ueberheide, B., Wisniewski, T., & Drummond, E. (2023) · Nature Communications · doi:10.1038/s41467-023-40208-x · Cited by 174 · see citing works

Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

Meftah, S., & Gan, J. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1129036 · Cited by 197 · see citing works

Loss of lamin‐B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus

Matias, I., Diniz, L. P., Damico, I. V., Araujo, A. P. B., Neves, L. D. S., Vargas, G., Leite, R. E. P., Suemoto, C. K., Nitrini, R., Jacob‐Filho, W., et al. (2022) · Aging Cell · doi:10.1111/acel.13521 · Cited by 183 · see citing works

Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease

Zalocusky, K. A., Najm, R., Taubes, A. L., Hao, Y., Yoon, S. Y., Koutsodendris, N., Nelson, M. R., Rao, A., Bennett, D. A., Bant, J., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00851-3 · Cited by 189 · see citing works

Frontotemporal lobar degeneration

Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178 · see citing works

Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges

Rahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T. T., Akter, R., Jeong, Y. J., Goh, S. H., Kim, C.-S., & Lee, K.-J. (2021) · Molecules · doi:10.3390/molecules26175327 · Cited by 182 · see citing works

Wilson’s disease: update on pathogenesis, biomarkers and treatments

Shribman, S., Poujois, A., Bandmann, O., Członkowska, A., & Warner, T. T. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326123 · Cited by 166 · see citing works

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Vogel, J. W., Corriveau‐Lecavalier, N., Franzmeier, N., Pereira, J. B., Brown, J. A., Maaß, A., Botha, H., Seeley, W. W., Bassett, D. S., Jones, D. T., et al. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00731-8 · Cited by 160 · see citing works

Targeting synapse function and loss for treatment of neurodegenerative diseases

Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 168 · see citing works

The basis of cellular and regional vulnerability in Alzheimer’s disease

Mrdjen, D., Fox, E., Bukhari, S., Montine, K., Bendall, S., & Montine, T. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02054-4 · Cited by 133 · see citing works

Cerebral Iron Deposition in Neurodegeneration

Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159 · see citing works

The Muscle-Brain Axis and Neurodegenerative Diseases: The Key Role of Mitochondria in Exercise-Induced Neuroprotection

Burtscher, J., Millet, G. P., Place, N., Kayser, B., & Zanou, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126479 · Cited by 159 · see citing works

Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease

Arbo, B. D., André‐Miral, C., Nasre‐Nasser, R. G., Schimith, L. E., dos Santos, M. G., da Costa-Silva, D. G., Muccillo-Baisch, A. L., & Hort, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00103 · Cited by 156 · see citing works

Precision drug delivery to the central nervous system using engineered nanoparticles

Gao, J., Xia, Z. J., Gunasekar, S., Jiang, C., Karp, J. M., & Joshi, N. (2024) · Nature Reviews Materials · doi:10.1038/s41578-024-00695-w · Cited by 162 · see citing works

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

Khalaf, K., Tornese, P., Cocco, A., & Albanese, A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00307-z · Cited by 150 · see citing works

Regional, Layer, and Cell-Type-Specific Connectivity of the Mouse Default Mode Network

Whitesell, J. D., Liska, A., Coletta, L., Hirokawa, K. E., Bohn, P., Williford, A., Groblewski, P. A., Graddis, N., Kuan, L., Knox, J. E., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.11.011 · Cited by 134 · see citing works

Lysosomal Dysfunction at the Centre of Parkinson’s Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis

Wallings, R. L., Humble, S. W., Ward, M. E., & Wade‐Martins, R. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.10.002 · Cited by 143 · see citing works

Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease

Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01494-6 · Cited by 141 · see citing works

Inflammatory aspects of Alzheimer’s disease

Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 143 · see citing works

Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review

Wdowiak, K., Walkowiak, J., Pietrzak, R., Bazan‐Wozniak, A., & Cielecka‐Piontek, J. (2022) · Nutrients · doi:10.3390/nu14132647 · Cited by 122 · see citing works

Cell Death and NeurodegenerationPreprint

Andreone, B. J., Larhammar, M., & Lewcock, J. W. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036434 · Cited by 122 · see citing works

Neuropathogenesis-on-chips for neurodegenerative diseases

Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 120 · see citing works

Molecular Pathophysiological Mechanisms in Huntington’s Disease

Jurcău, A. (2022) · Biomedicines · doi:10.3390/biomedicines10061432 · Cited by 111 · see citing works

The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis

Zhao, J., Wang, X., Huo, Z., Chen, Y., Liu, J., Zhao, Z., Meng, F., Su, Q., Bao, W., Zhang, L., et al. (2022) · Cells · doi:10.3390/cells11132049 · Cited by 115 · see citing works

When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration

Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 112 · see citing works

Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain

Rayaprolu, S., Bitarafan, S., Santiago, J. V., Betarbet, R. S., Sunna, S. N., Cheng, L., Xiao, H., Nelson, R. S., Kumar, P., Bagchi, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30623-x · Cited by 109 · see citing works

Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases

Tittelmeier, J., Nachman, E., & Nussbaum-Krammer, C. I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581374 · Cited by 107 · see citing works

Mitochondrial calcium cycling in neuronal function and neurodegeneration

Walters, G. C., & Usachev, Y. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1094356 · Cited by 105 · see citing works

Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease

Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk1051 · Cited by 101 · see citing works

Data-driven modelling of neurodegenerative disease progression: thinking outside the black box

Young, A. L., Oxtoby, N. P., Garbarino, S., Fox, N. C., Barkhof, F., Schott, J. M., & Alexander, D. C. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00779-6 · Cited by 103 · see citing works

Focusing on mitochondria in the brain: from biology to therapeutics

Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 102 · see citing works

New perspectives on the basal forebrain cholinergic system in Alzheimer’s disease

Berry, A. S., & Harrison, T. M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105192 · Cited by 97 · see citing works

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

Vogels, T., Leuzy, A., Cicognola, C., Ashton, N. J., Smolek, T., Novák, M., Blennow, K., Zetterberg, H., Hromádka, T., Žilka, N., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.019 · Cited by 94 · see citing works

tRNA Metabolism and Neurodevelopmental Disorders

Schaffer, A. E., Pinkard, O. W., & Coller, J. M. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015334 · Cited by 92 · see citing works

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

Yang, S., Park, J. H., & Lu, H.-C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00634-3 · Cited by 94 · see citing works

Region-specific vulnerability in neurodegeneration: lessons from normal ageing

Pandya, V. A., & Patani, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101311 · Cited by 94 · see citing works

The immune system on the TRAIL of Alzheimer’s disease

Burgaletto, C., Munafò, A., Benedetto, G. D., Francisci, C. D., Caraci, F., Mauro, R. D., Bucolo, C., Bernardini, R., & Cantarella, G. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01968-1 · Cited by 92 · see citing works

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 93 · see citing works

Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders

Kip, E., & Parr‐Brownlie, L. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1092537 · Cited by 96 · see citing works

Targeting the proteostasis network in Huntington’s disease

Soares, T. R., Reis, S., Pinho, B. R., Duchen, M. R., & Oliveira, J. M. A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.006 · Cited by 89 · see citing works

Mesenchymal stem cells as a multimodal treatment for nervous system diseases

Badyra, B., Sułkowski, M., Milczarek, O., & Majka, M. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0430 · Cited by 86 · see citing works

Advances in transcriptome analysis of human brain aging

Ham, S., & Lee, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00522-6 · Cited by 81 · see citing works

Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease

Qian, K., Bao, X., Li, Y., Wang, P., Guo, Q., Yang, P., Xu, S., Yu, F., Meng, R., Cheng, Y., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05795 · Cited by 87 · see citing works

Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases

Sandhu, J. K., & Kulka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031093 · Cited by 85 · see citing works

Pathomechanisms in the neuronal ceroid lipofuscinoses

Nelvagal, H. R., Lange, J., Takahashi, K., Tarczyluk-Wells, M. A., & Cooper, J. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165570 · Cited by 80 · see citing works

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Zhang, Z.-T., Tian, Y., & Ye, K. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0179-3 · Cited by 63 · see citing works

Evolutionary conservation and divergence of the human brain transcriptome

Pembroke, W. G., Hartl, C., & Geschwind, D. H. (2021) · Genome biology · doi:10.1186/s13059-020-02257-z · Cited by 78 · see citing works

Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model

Shimojo, M., Takuwa, H., Takado, Y., Tokunaga, M., Tsukamoto, S., Minatohara, K., Ono, M., Seki, C., Maeda, J., Urushihata, T., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2880-19.2020 · Cited by 78 · see citing works

Neurotoxic astrocytes express the d-serine synthesizing enzyme, serine racemase, in Alzheimer's disease

Balu, D. T., Pantazopoulos, H., Huang, C. C., Muszynski, K., Harvey, T. L., Uno, Y., Rorabaugh, J. M., Galloway, C. R., Botz-Zapp, C. A., Berretta, S., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104511 · Cited by 77 · see citing works

Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology

Hou, X., Watzlawik, J., Cook, C., Liu, C.-C., Kang, S. S., Lin, W.-L., DeTure, M., Heckman, M., Diehl, N., Al-Shaikh, F. S. H., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12198 · Cited by 66 · see citing works

Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease

Jagaran, K., & Singh, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169361 · Cited by 74 · see citing works

Going Too Far Is the Same as Falling Short†: Kinesin-3 Family Members in Hereditary Spastic Paraplegia

Gabrych, D. R., Lau, V. Z., Niwa, S., & Silverman, M. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00419 · Cited by 71 · see citing works

Emerging Roles of Complement Protein C1q in Neurodegeneration

Cho, K. (2019) · Aging and Disease · doi:10.14336/ad.2019.0118 · Cited by 73 · see citing works

Cellular and regional vulnerability in frontotemporal tauopathies

Forrest, S. L., Kril, J. J., & Halliday, G. M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02035-7 · Cited by 72 · see citing works

Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease

Olajide, O. J., Suvanto, M. E., & Chapman, C. A. (2021) · Biology Open · doi:10.1242/bio.056796 · Cited by 71 · see citing works

Brainwide Genetic Sparse Cell Labeling to Illuminate the Morphology of Neurons and Glia with Cre-Dependent MORF Mice

Veldman, M. B., Park, C. S., Eyermann, C. M., Zhang, J. Y., Zuniga-Sanchez, E., Hirano, A. A., Daigle, T. L., Foster, N. N., Zhu, M., Langfelder, P., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.07.019 · Cited by 71 · see citing works

A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade

Granzotto, A., Canzoniero, L. M. T., & Sensi, S. L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.600089 · Cited by 67 · see citing works

Repetitive elements in aging and neurodegeneration

Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70 · see citing works

The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease

Balusu, S., & Strooper, B. D. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02747-5 · Cited by 73 · see citing works

Cortical structure and the risk for Alzheimer’s disease: A bidirectional Mendelian randomization study

Wu, B.-S., Zhang, Y.-R., Li, H.-Q., Kuo, K., Chen, S.-D., Dong, Q., Liu, Y., & Yu, J.-T. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01599-x · Cited by 69 · see citing works

Transposable elements as new players in neurodegenerative diseases

Ravel‐Godreuil, C., Znaidi, R., Bonnifet, T., Joshi, R. L., & Fuchs, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14205 · Cited by 67 · see citing works

White matter damage and degeneration in traumatic brain injury.

Armstrong, R. C., Sullivan, G. M., Perl, D. P., Rosarda, J. D., & Radomski, K. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.07.003 · Cited by 62 · see citing works

The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration

Moreno-García, A., Kun, A., Calero, M., & Calero, O. (2021) · Antioxidants · doi:10.3390/antiox10010124 · Cited by 64 · see citing works

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics

Madhav, H., Jameel, E., Rehan, M., & Hoda, N. (2022) · RSC Medicinal Chemistry · doi:10.1039/d1md00394a · Cited by 60 · see citing works

Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease

Martino, R. M. C. D., Pruccoli, L., Bisi, A., Gobbi, S., Rampa, A., Martı́nez, A., Pérez, C., Martínez‐González, L., Paglione, M., Schiavi, E. D., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00363 · Cited by 60 · see citing works

Cholinergic white matter pathways along the Alzheimer's disease continuum

Němý, M., Dyrba, M., Brosseron, F., Büerger, K., Dechent, P., Dobisch, L., Ewers, M., Fließbach, K., Glanz, W., Göerß, D., et al. (2022) · Brain · doi:10.1093/brain/awac385 · Cited by 58 · see citing works

Neuronal identity defines α-synuclein and tau toxicity

Praschberger, R., Kuenen, S., Schoovaerts, N., Kaempf, N., Singh, J., Janssens, J., Swerts, J., Nachman, E., Calatayud, C., Aerts, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.033 · Cited by 59 · see citing works

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Liang, Y., Cui, L., Gao, J., Zhu, M., Zhang, Y., & Zhang, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02375-0 · Cited by 59 · see citing works

A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model

Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58 · see citing works

Amyotrophic Lateral Sclerosis (ALS): Stressed by Dysfunctional Mitochondria-Endoplasmic Reticulum Contacts (MERCs)

Chen, J., Bassot, A., Giuliani, F., & Simmen, T. (2021) · Cells · doi:10.3390/cells10071789 · Cited by 57 · see citing works

Thermodynamic analysis of amyloid fibril structures reveals a common framework for stability in amyloid polymorphs

van der Kant, R., Louros, N. N., Schymkowitz, J. W. H., & Rousseau, F. (2022) · Structure · doi:10.1016/j.str.2022.05.002 · Cited by 54 · see citing works

Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease

Venkataraman, L., Fair, S. R., McElroy, C. A., Hester, M. E., & Fu, H. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10068-9 · Cited by 54 · see citing works

Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer’s Disease Continuum

Iaccarino, L., Joie, R. L., Edwards, L., Strom, A., Schonhaut, D. R., Ossenkoppele, R., Pham, J. Q., Mellinger, T. J., Janabi, M., Baker, S. L., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa184 · Cited by 55 · see citing works

Development of a Sensitive, Scalable Method for Spatial, Cell-Type-Resolved Proteomics of the Human Brain

Davis, S. A., Scott, C., Ansorge, O., & Fischer, R. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00981 · Cited by 54 · see citing works

In Vivo Chimeric Alzheimer’s Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons

Najm, R., Zalocusky, K. A., Zilberter, M., Yoon, S. Y., Hao, Y., Koutsodendris, N., Nelson, M., Rao, A., Taubes, A., Jones, E. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107962 · Cited by 52 · see citing works

Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease

Therriault, J., Pascoal, T. A., Savard, M., Mathotaarachchi, S. S., Benedet, A. L., Chamoun, M., Tissot, C., Lussier, F. Z., Rahmouni, N., Stevenson, J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8693 · Cited by 54 · see citing works

Ngly1 −/− rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems

Asahina, M., Fujinawa, R., Nakamura, S., Yokoyama, K., Tozawa, R., & Suzuki, T. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa059 · Cited by 53 · see citing works

Network Tau spreading is vulnerable to the expression gradients of <i>APOE</i> and glutamatergic-related genes

Montal, V., Diez, I., Kim, C.-M., Orwig, W., Bueichekú, E., Gutiérrez-Zúñiga, R., Bejanin, A., Pegueroles, J., Dols-Icardo, O., Vannini, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn7273 · Cited by 52 · see citing works

Machine learning in the clinical and language characterisation of primary progressive aphasia variants

Matias-Guiu, J. A., Díaz-Álvarez, J., Cuetos, F., Cabrera-Martín, M. N., Segovia-Ríos, I., Pytel, V., Moreno-Ramos, T., Carreras, J. L., Matías-Guiu, J., & Ayala, J. L. (2019) · Cortex · doi:10.1016/j.cortex.2019.05.007 · Cited by 50 · see citing works

Neuroprotective Effects of Sodium Butyrate through Suppressing Neuroinflammation and Modulating Antioxidant Enzymes

Bayazid, A. B., Jang, Y., Kim, Y. M., Kim, J. G., & Lim, B. O. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03369-z · Cited by 54 · see citing works

Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases

Kampmann, M. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00806-0 · Cited by 138 · see citing works

Alzheimer's Disease Selective Vulnerability and Modelling in Transgenic Mice

Götz, J., Nicole, S., Vissel, B., & Ittner, L. M. (2011) · Advances in Alzheimer's disease · doi:10.3233/978-1-60750-733-8-49 · Cited by 1 · see citing works

Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice

Götz, J., Schönrock, N., Vissel, B., & Ittner, L. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1143 · Cited by 36 · see citing works

Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration

Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 561 · see citing works

Catastrophic cliffs: a partial suggestion for selective vulnerability in neurodegenerative diseases

Hardy, J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150287 · Cited by 15 · see citing works